These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 22728861)
1. Variability of phenotype in two sisters with pyridoxine dependent epilepsy. Alfadhel M; Sirrs S; Waters PJ; Szeitz A; Struys E; Coulter-Mackie M; Stockler-Ipsiroglu S Can J Neurol Sci; 2012 Jul; 39(4):516-9. PubMed ID: 22728861 [TBL] [Abstract][Full Text] [Related]
2. Profound neonatal hypoglycemia and lactic acidosis caused by pyridoxine-dependent epilepsy. Mercimek-Mahmutoglu S; Horvath GA; Coulter-Mackie M; Nelson T; Waters PJ; Sargent M; Struys E; Jakobs C; Stockler-Ipsiroglu S; Connolly MB Pediatrics; 2012 May; 129(5):e1368-72. PubMed ID: 22529283 [TBL] [Abstract][Full Text] [Related]
3. Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy. Al Teneiji A; Bruun TU; Cordeiro D; Patel J; Inbar-Feigenberg M; Weiss S; Struys E; Mercimek-Mahmutoglu S Metab Brain Dis; 2017 Apr; 32(2):443-451. PubMed ID: 27882480 [TBL] [Abstract][Full Text] [Related]
4. Pyridoxine-dependent epilepsy with elevated urinary α-amino adipic semialdehyde in molybdenum cofactor deficiency. Struys EA; Nota B; Bakkali A; Al Shahwan S; Salomons GS; Tabarki B Pediatrics; 2012 Dec; 130(6):e1716-9. PubMed ID: 23147983 [TBL] [Abstract][Full Text] [Related]
6. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Stockler S; Plecko B; Gospe SM; Coulter-Mackie M; Connolly M; van Karnebeek C; Mercimek-Mahmutoglu S; Hartmann H; Scharer G; Struijs E; Tein I; Jakobs C; Clayton P; Van Hove JL Mol Genet Metab; 2011; 104(1-2):48-60. PubMed ID: 21704546 [TBL] [Abstract][Full Text] [Related]
7. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency. Coughlin CR; Tseng LA; Abdenur JE; Ashmore C; Boemer F; Bok LA; Boyer M; Buhas D; Clayton PT; Das A; Dekker H; Evangeliou A; Feillet F; Footitt EJ; Gospe SM; Hartmann H; Kara M; Kristensen E; Lee J; Lilje R; Longo N; Lunsing RJ; Mills P; Papadopoulou MT; Pearl PL; Piazzon F; Plecko B; Saini AG; Santra S; Sjarif DR; Stockler-Ipsiroglu S; Striano P; Van Hove JLK; Verhoeven-Duif NM; Wijburg FA; Zuberi SM; van Karnebeek CDM J Inherit Metab Dis; 2021 Jan; 44(1):178-192. PubMed ID: 33200442 [TBL] [Abstract][Full Text] [Related]
8. Seizure recurrence following pyridoxine withdrawal in a patient with pyridoxine-dependent epilepsy. Tamaura M; Shimbo H; Iai M; Yamashita S; Osaka H Brain Dev; 2015 Apr; 37(4):442-5. PubMed ID: 25123644 [TBL] [Abstract][Full Text] [Related]
9. Metabolomics analysis of antiquitin deficiency in cultured human cells and plasma: Relevance to pyridoxine-dependent epilepsy. Crowther LM; Poms M; Zandl-Lang M; Abela L; Hartmann H; Seiler M; Mathis D; Plecko B J Inherit Metab Dis; 2023 Jan; 46(1):129-142. PubMed ID: 36225138 [TBL] [Abstract][Full Text] [Related]
16. Current knowledge for pyridoxine-dependent epilepsy: a 2016 update. Pena IA; MacKenzie A; Van Karnebeek CDM Expert Rev Endocrinol Metab; 2017 Jan; 12(1):5-20. PubMed ID: 30058881 [TBL] [Abstract][Full Text] [Related]
17. Disrupted de novo pyrimidine biosynthesis impairs adult hippocampal neurogenesis and cognition in pyridoxine-dependent epilepsy. Yan J; Wu J; Xu M; Wang M; Guo W Sci Adv; 2024 Apr; 10(14):eadl2764. PubMed ID: 38579001 [TBL] [Abstract][Full Text] [Related]
18. A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency. Al-Shekaili HH; Petkau TL; Pena I; Lengyell TC; Verhoeven-Duif NM; Ciapaite J; Bosma M; van Faassen M; Kema IP; Horvath G; Ross C; Simpson EM; Friedman JM; van Karnebeek C; Leavitt BR Hum Mol Genet; 2020 Nov; 29(19):3266-3284. PubMed ID: 32969477 [TBL] [Abstract][Full Text] [Related]